Aug 3, 2016 Cellectar Biosciences Announces $2 Million NCI SBIR Contract for a Phase 2 Clinical Study Learn More
Jul 20, 2016 Cellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations Learn More
Jun 23, 2016 Cellectar Biosciences Announces Results of NCI-Sponsored Study of CLR 125 Showing Potential Effect Against Triple Negative Breast Cancer Learn More
Jun 15, 2016 Cellectar Biosciences Announces Results of In Vivo Study Demonstrating PDC Platform Delivery of Paclitaxel to be Superior in Tumor Targeting to Free Paclitaxel Learn More